PUBLISHED DATE : Jan 2022 | Pages : 281
Fill out your details & get your free sample
The Global Medical Exoskeleton Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.
281 Pages
109 Tables
126 Charts
5 Regions
18 Countries
29 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 3,816.17 MILLION (2027) |
| CAGR (REVENUE) | OVER 36% (2022-2027) |
| BASE YEAR | 2021 |
| FORECAST PERIOD | 2022 – 2027 |
| MARKET SEGMENTS | Modality (Powered Exoskeletons and Passive Exoskeletons), Extremity (Lower Extremity Exoskeletons and Upper Extremity Exoskeletons), Mobility (Mobile Exoskeletons and Stationary Exoskeletons), and Usage (Rehabilitation Exoskeletons and Augmentation Exoskeletons) |
| GEOGRAPHICAL ANALYSIS | North America, Europe, APAC, Latin America and Middle East and Africa |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Spain, Italy, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa. |
The global medical exoskeleton market size is expected to reach USD 3.81 billion by 2027, growing with a compound annual growth (CAGR) of 36.29% from 2022-2027. Factors like a growing incidence of major trauma, such as stroke, cerebral palsy, and neuropathy, contribute to the medical exoskeleton market growth. Most countries also have an aging population with a high risk of stroke and SCI, among other complications. Often, these diseases are not entirely curable by medication, so doctors advise rehabilitation. According to the WHO, 15% of the world’s population (an estimated 1.1 billion people) have some form of disability.
The growing number of physical disabilities leading has boosted the growth of the global medical exoskeleton market. Medical exoskeletons are used to power disabled, injured, or vulnerable individuals who are suffering from various medical reasons such as SCI, neuropathy, major trauma such as stroke, and cerebral palsy. Mainly, these types of medical exoskeletons are used in monitored settings such as hospitals and rehab centers under the supervision of medical professionals.
In terms of geography, the global medical exoskeleton market is dominated by North America, with the largest revenue share of 40.00%. It is expected to witness the highest incremental growth of USD 1.30 billion during the forecast period. Further, Europe is expected to have the fastest growth in the exoskeleton market.
The NSCISC reported that as of 2020, there were 294,000 persons in the U.S. living with SCI, with an annual incidence of approximately 17,810 new cases. In addition, the stroke rate in the US is 795,000 incidences per year, and the survival rate is nearly 80%. In this stroke population, 80% are left with some lower limb disability. Further, 13.7% have a mobility disability with severe walking and climbing stairs. Such factors are contributing to the growth of the medical exoskeleton market.
Increasing insurance coverage for medical exoskeletons with the efforts of the exoskeleton companies is a significant growth trend in the medical exoskeleton market. ReWalk Robotics, a developer of medical exoskeletons for people with lower extremity disabilities, said it was progressing with a group of German legal health insurers to allow anyone with a spinal cord injury (SCI) to get an exoskeletal system.
Development of 3D-Printed Medical Exoskeletons
Today, 3D printing is used in various biomedical fields. This technique can fabricate metal implants in hard tissue and organ growth, print copies of anatomical models for surgical preparation, dental and orthotic fixators, etc. 3D-printed exoskeletons allow disabled people to lead normal life. Low cost, mobilization, and adaptation to special needs are a few advantages favoring the growth of the medical exoskeleton market. Researchers worldwide are working to develop an affordable, lightweight, and inexpensive exoskeleton. The application of additive manufacturing technology will reduce the cost of the rehabilitation process, making it more personalized and convenient and helping to alleviate the difficulties of daily life.
Increasing Focus on Brain-Machine Interface-Based Medical Exoskeletons
Over the past decade, robotic exoskeleton devices (wearable robots) have been developed as a convenient additional system for therapists to treat damaged joints or limbs. The exoskeleton robot can efficiently integrate the cognitive abilities of a human and the benefits of robotic techniques to help users perform activities. These devices were developed in full-limbed exoskeletons to upper and lower limb exoskeletons and other exoskeleton robots to strengthen shoulders, elbows, wrists, and ankles.
In late 2017, the most advanced version of the exoskeleton, HAL, Hybrid Assistive Limb, received FDA approval for use as an adjunct to medical procedures. This version can sense electrical signals coming from the brain and reaching the muscles of the limbs. These signals are decoded and "enter" the exoskeleton, generating commands to help with movement.
Increasing Number of People with Physical Disabilities
A physical disability is a major and long-term illness that affects or limits a person’s physical function, mobility, endurance, or dexterity. Approximately 15% of the world's population lives with some form of disability, of which 24% have significant functional impairments. This global estimate of disability is increasing due to an aging population, the rapid spread of chronic diseases, and improved methods of measuring disability.
According to the United Nations Development Program, 80% of people with disabilities live in developing countries. Physical disabilities can have a variety of causes, but also inherited or genetic disorders, serious illnesses, and injuries. This patient population seeks treatment at inpatient, outpatient, and therapy-offering rehabilitation clinics and qualified care centers. Physicians also recommend medical exoskeletons majorly for stroke rehabilitation. The types of physical disabilities include acquired brain injuries, spinal cord injury (SCI), spina bifida, cerebral palsy, and muscular dystrophy. Thus, increasing strokes, SCI, ABI, CNS, CVS, and Spina bifida cases contribute to the global medical exoskeleton market growth.
INSIGHTS BY MODALITY
The global medical exoskeleton market is segmented based on modality into the powered and passive exoskeleton. The powered exoskeleton segment accounts for 86.84% of the global market share. Motorized exoskeletons allow people with spinal cord injuries and similar injuries to move freely in and out of the hospital. This technology has been shown to affect mental well-being by improving quality of life and reducing anxiety and depressive symptoms. Exoskeletons can provide an opportunity for people with SCI to independently enhance their level of physical activity.
INSIGHTS BY EXTREMITY
The global medical exoskeleton market is segmented into the upper extremity and lower extremity exoskeleton on the basis of extremity. The lower extremity exoskeleton market is expected to reach USD 2.85 billion by 2027 and is anticipated to retain its market dominance during the forecast period. A rehabilitation exoskeleton that serves people directly has many possible uses in rehabilitation sessions. Therefore, there is great value in developing advanced rehabilitation exoskeletons. Research on robots for lower limb rehabilitation in patients with limb movement disorders is an integral part of research on rehabilitation robots.
INSIGHTS BY MOBILITY
Based on mobility, the global medical exoskeleton market is segmented into stationary exoskeletons and mobile exoskeletons. The mobile exoskeleton segment accounted for a significant share of 68.55% in 2021. The mobile exoskeleton is anticipated to retain its market dominance during the forecast period. Mobile exoskeletons designed to assist human movement are used in daily life, such as getting up, sitting, etc., in patients who have lost their lower limb mobility due to diseases such as SCI and multiple sclerosis. Several active mobile medical exoskeleton systems have been developed to assist with paraplegia in the corridor. The three most popular devices for paraplegic patients, ReWalk, eLegs, and Indego, use four degrees of freedom of movement (one on each hip and one on each knee) to facilitate walking. Mobile medical exoskeletons include Austin Exoskeleton, Indego, ReWalk, eLegs, and Rex.
INSIGHTS BY TYPE
The global medical exoskeleton market is segmented based on type into rehabilitation and augmentation exoskeletons. The rehabilitation segment accounts for 86.64% and is anticipated to retain its market dominance during the forecast period. The application of exoskeletons in the rehabilitation of paraplegic patients has shown promising results for recovering patients with movement disorders. Various manufacturers develop several exoskeletons. These exoskeletons have advanced over time to help patients suffering from paraplegia caused by a variety of medical conditions.
The global medical exoskeleton market is likely to witness increasing growth during the forecast period, with a rise in physical disabilities across various healthcare settings. North America dominates the market with the highest share of 40%, and Europe has the second-highest percentage of 30%. North America emerged as a leading region which is contributed by an increasing elderly population, the prevalence of chronic illness, increasing strokes, a rise in the number of rehabilitation centers, a rise in prescriptions and hospitalization rates, an increase in government funding and healthcare expenditures, as well as growing awareness of technological developments. The strong presence of key medical exoskeleton companies is another reason for the high uptake of medical exoskeletons in North America. The United States is the main area of innovation, with 36% of exoskeleton companies. The region has also shown high healthcare spending in its GDP, which helps develop advanced exoskeletons.
Europe is the second major contributor to the global medical exoskeleton market, with increasing demand for advanced medical devices for chronic conditions. The rise in the prevalence of acute and chronic conditions, increase in rehabilitation center admissions, a growing number of prescriptions, and others are also contributing to the market growth in the region. The medical exoskeleton market in Europe is dominated by Germany, France, the UK, Italy, and Spain.
The Asia-Pacific region has many exoskeleton developers actively developing innovative medical exoskeletons at affordable costs. APAC is projected to grow at a lucrative rate due to increased stroke incidences, an aging population with related health conditions, favorable government policies, and growing healthcare expenditures. China, Japan, Australia, India, and South Korea are major countries contributing to the exponential growth of the market in this region. The region is estimated to have 690 million people living with disabilities. That number can increase due to the aging of the population, chronic health conditions, road accidents, and climate-related disasters.
The key market players accounting for a significant share in the global medical exoskeleton market are ReWalk Robotics, Ekso Bionics, Parker Hannifin, Ottobock, Cyberonics, Rex Bionics, and DIH Medical. Key vendors have a broad geographical reach, diversified product portfolio, and a strong focus on innovation and research activities. There is a massive pool of many other mid-sized and emerging vendors contributing to the market's growth. Most leading players focus on implementing various strategies such as introducing soft actuators and affordable costs, marketing and promotional activities, acquisitions, increased R&D investments, and strengthened distribution networks to enhance their share and presence in the market.
The global medical exoskeleton market potential attracts many startups to invest in the industry and intensifies competition. Many companies increase their market presence by introducing new products, expanding operations, or strategic mergers and acquisitions. According to Cyberdyne, HAL is the world's first cyborg robot. However, in the medical setting, HAL is a machine that works with patients to improve their physical function and allow them to walk again.
Key Developments
Frequently Asked Questions
What is the expected growth of the global medical exoskeleton market?
The global medical exoskeleton market size is expected to reach USD 3.81 billion by 2027.
What is the growth rate of the global medical exoskeleton market?
The global medical exoskeleton market is growing with a CAGR of 36.29% from 2022 to 2027.
Who are the key players in the global medical exoskeleton market?
Ekso Bionics, ReWalk Robotics, PARKER HANNIFIN, Ottobock, CYBERDYNE, Rex Bionics, and DIH Medical are key global companies with medical exoskeleton market share.
Which region dominates the global medical exoskeleton market?
North America dominates the medical exoskeleton market with a market share of 40%. An increasing elderly population, the prevalence of chronic illness, increasing strokes, a rise in the number of rehabilitation centers, a rise in prescriptions and hospitalization rates, an increase in government funding and healthcare expenditures, and growing awareness of technological developments are key factors behind the North America market domination.
What are the latest trends in the medical exoskeleton market?
The emergence of soft actuator medical exoskeletons, the development of 3d-printed medical exoskeletons, and the increasing focus on brain-machine interface-based medical exoskeletons are some of the latest trends in the latest trends in the medical exoskeleton market.
The medical exoskeleton market by revenue is expected to grow at a CAGR of over 36% during the period 2022–2027.
The following factors are likely to contribute to the growth of the medical exoskeleton market.
Base Year: 2021
Forecast year: 2022-2027
The report considers the present scenario of the medical exoskeleton market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
PROMINENT VENDORS
OTHER PROMINENT VENDORS
Market Segmentation by Modality
Market Segmentation by Extremity
Market Segmentation by Mobility
Market Segmentation by Usage
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segmentation
4.4.1 Market Segmentation by Modality
4.4.2 Market Segmentation by Extremity
4.4.3 Market Segmentation by Mobility
4.4.4 Market Segmentation by Type
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Emergence of Soft Actuator Medical Exoskeletons
8.2 Development Of 3d-Printed Medical Exoskeletons
8.3 Increasing Focus on Brain-Machine Interface Based Medical Exoskeletons
9 Market Growth Enablers
9.1 Increasing Number of People with Physical Disabilities
9.2 Recent Advancements in Medical Exoskeletons
9.3 Increasing Insurance Coverage for Medical Exoskeletons
10 Market Restraints
10.1 High Cost of Medical Exoskeletons
10.2 Greater Preference for Wheelchairs
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Modality
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Powered Exoskeleton
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Powered Exoskeleton: Geography Segmentation
12.4 Passive Exoskeleton
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Passive Exoskeleton: Geography Segmentation
13 Extremity
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Lower Extremity Exoskeletons
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Lower Extremity Exoskeleton: Geography Segmentation
13.4 Upper Extremity Exoskeletons
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Upper Extremity Exoskeleton: Geography Segmentation
14 Mobility
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Mobile Exoskeletons
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Mobile Exoskeleton: Geography Segmentation
14.4 Stationary Exoskeletons
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Stationary Exoskeleton: Geography Segmentation
15 Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Rehabilitation Exoskeletons
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Rehabilitation Exoskeleton: Geography Segmentation
15.4 Augmentation Exoskeletons
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Augmentation Exoskeleton: Geography Segmentation
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.2.1 North America: Modality Segmentation
17.2.2 North America: Extremity Segmentation
17.2.3 North America: Mobility Segmentation
17.2.4 North America: Type Segmentation
17.3 Key Countries
17.3.1 US: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Europe: Modality Segmentation
18.2.2 Europe: Extremity Segmentation
18.2.3 Europe: Mobility Segmentation
18.2.4 Europe: Type Segmentation
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 UK: Market Size & Forecast
18.3.3 France: Market Size & Forecast
18.3.4 Spain: Market Size & Forecast
18.3.5 Italy: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 APAC: Modality Segmentation
19.2.2 APAC: Extremity Segmentation
19.2.3 APAC: Mobility Segmentation
19.2.4 APAC: Type Segmentation
19.3 Key Countries
19.3.1 China: Market Size & Forecast
19.3.2 Japan: Market Size & Forecast
19.3.3 India: Market Size & Forecast
19.3.4 Australia: Market Size & Forecast
19.3.5 South Korea: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 Latin America: Modality Segmentation
20.2.2 Latin America: Extremity Segmentation
20.2.3 Latin America: Mobility Segmentation
20.2.4 Latin America: Type Segmentation
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Middle East & Africa: Modality Segmentation
21.2.2 Middle East & Africa: Extremity Segmentation
21.2.3 Middle East & Africa: Mobility Segmentation
21.2.4 Middle East & Africa: Type Segmentation
21.3 Key Countries
21.3.1 Turkey: Market Size & Forecast
21.3.2 Saudi Araba: Market Size & Forecast
21.3.3 South Africa: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
23 Key Company Profiles
23.1 EKSO BIONICS
23.1.1 Business Overview
23.1.2 Ekso Bionics in The Medical Exoskeleton Market
23.1.3 Product Offerings
23.1.4 Key Strategies
23.1.5 Key Strengths
23.1.6 Key Opportunities
23.2 REWALK ROBOTICS
23.2.1 Business Overview
23.2.2 Rewalk Robotics in The Medical Exoskeleton Market
23.2.3 Product Offerings
23.2.4 Key Strategies
23.2.5 Key Strengths
23.2.6 Key Opportunities
23.3 PARKER-HANNIFIN
23.3.1 Business Overview
23.3.2 Parker Hannifin in The Medical Exoskeleton Market
23.3.3 Product Offerings
23.3.4 Key Strategies
23.3.5 Key Strengths
23.3.6 Key Opportunities
23.4 OTTOBOCK
23.4.1 Business Overview
23.4.2 Ottobock in The Medical Exoskeleton Market
23.4.3 Product Offerings
23.4.4 Key Strategies
23.4.5 Key Strengths
23.4.6 Key Opportunities
23.5 CYBERDYNE
23.5.1 Business Overview
23.5.2 Cyberdyne in The Medical Exoskeleton Market
23.5.3 Product Offerings
23.5.4 Key Strategies
23.5.5 Key Strengths
23.5.6 Key Opportunities
23.6 REX BIONICS
23.6.1 Business Overview
23.6.2 Rex Bionics in Medical Exoskeleton
23.6.3 Product Offerings
23.6.4 Key Strategies
23.6.5 Key Strengths
23.6.6 Key Opportunities
23.7 DIH MEDICAL
23.7.1 Business Overview
23.7.2 Dih Medical in The Medical Exoskeleton Market
23.7.3 Product Offerings
23.7.4 Key Strategies
23.7.5 Key Strengths
23.7.6 Key Opportunities
24 Other Prominent Vendors
24.1 WEARABLE ROBOTICS
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 GOGOA
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 EXOATLET
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 PANASONIC
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 TYROMOTION
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 HONDA
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 B-TEMIA
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 BIONIC POWER
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 ANGEL ROBOTICS
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 AXOSUITS
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 BAMA TEKNOLOJI
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 BIOMOTUM
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 BIONIC YANTRA
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 BIOSERVO TECHNOLOGIES
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 FOURIER INTELLIGENCE
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 FREE BIONICS
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 GLOREHA IDROGENET
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 HARMONIC BIONICS
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 HEXAR HUMANCARE
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 HUMAN IN MOTION ROBOTICS
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 INTESPRING
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 MARSI BIONICS
24.22.1 Business Overview
24.22.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market by Modality
26.1.1 North America: Modality Segmentation
26.1.2 Europe: Modality Segmentation
26.1.3 APAC: Modality Segmentation
26.1.4 Latin America: Modality Segmentation
26.1.5 Middle East & Africa: Modality Segmentation
26.2 Market by Extremity
26.2.1 North America: Extremity Segmentation
26.2.2 Europe: Extremity Segmentation
26.2.3 APAC: Extremity Segmentation
26.2.4 Latin America: Extremity Segmentation
26.2.5 Middle East & Africa: Extremity Segmentation
26.3 Market by Mobility
26.3.1 North America: Mobility Segmentation
26.3.2 Europe: Mobility Segmentation
26.3.3 APAC: Mobility Segmentation
26.3.4 Latin America: Mobility Segmentation
26.3.5 Middle East & Africa: Mobility Segmentation
26.4 Market by Type
26.4.1 North America: Type Segmentation
26.4.2 Europe: Type Segmentation
26.4.3 APAC: Type Segmentation
26.4.4 Latin America: Type Segmentation
26.4.5 Middle East & Africa: Type Segmentation
26.5 Market by Geography
26.5.1 Powered Exoskeleton
26.5.2 Passive Exoskeleton
26.5.3 Upper Extremity Exoskeleton
26.5.4 Lower Extremity Exoskeleton
26.5.5 Stationary Exoskeleton
26.5.6 Mobile Exoskeleton
26.5.7 Rehabilitation Exoskeleton
26.5.8 Augmentation Exoskeleton
27 Appendix
27.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Medical Exoskeleton Market
Exhibit 2 Market Size Calculation Approach 2021
Exhibit 3 Classification of Exoskeletons Based on End-Users
Exhibit 4 A Typical Model of Technical Regulatory System
Exhibit 5 Impact of the Emergence of Soft Actuator Medical Exoskeletons
Exhibit 6 Impact of Development of 3D-Printed Medical Exoskeletons
Exhibit 7 Impact of Increasing Focus on Brain-Machine Interface Based Medical Exoskeletons
Exhibit 8 Impact of Increasing Number of People with Physical Disabilities
Exhibit 9 Impact of Recent Advancements in Medical Exoskeletons
Exhibit 10 Impact of Increasing Insurance Coverage for Medical Exoskeletons
Exhibit 11 Impact of High Cost of Medical Exoskeletons
Exhibit 12 Impact of Greater Preference for Wheelchairs
Exhibit 13 Global Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 14 Five Forces Analysis 2021
Exhibit 15 Incremental Growth by Modality 2021 & 2027
Exhibit 16 Global Medical Exoskeleton Market by Modality
Exhibit 17 Global Medical Exoskeleton Market by Modality: Incremental Growth
Exhibit 18 Global Medical Exoskeleton Market by Modality: Absolute Growth
Exhibit 19 Global Powered Medical Exoskeleton Market: Incremental & Absolute Growth Comparison
Exhibit 20 Global Powered Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 21 Incremental Growth by Geography 2021 & 2027
Exhibit 22 Global Passive Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 23 Global Passive Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 24 Incremental Growth by Geography 2021 & 2027
Exhibit 25 Incremental Growth by Extremity 2021 & 2027
Exhibit 26 Global Medical Exoskeleton Market by Extremity
Exhibit 27 Global Medical Exoskeleton Market by Extremity: Incremental Growth
Exhibit 28 Global Medical Exoskeleton Market by Extremity: Absolute Growth
Exhibit 29 Global Lower Extremity Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 30 Global Lower Extremity Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 31 Incremental Growth by Geography 2021 & 2027
Exhibit 32 Global Upper Extremity Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 33 Global Upper Extremity Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 34 Incremental Growth by Geography 2021 & 2027
Exhibit 35 Incremental Growth by Mobility 2021 & 2027
Exhibit 36 Global Medical Exoskeleton Market by Mobility
Exhibit 37 Global Medical Exoskeleton Market by Mobility: Incremental Growth
Exhibit 38 Global Medical Exoskeleton Market by Mobility: Absolute Growth
Exhibit 39 Global Mobile Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 40 Global Mobile Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 41 Incremental Growth by Geography 2021 & 2027
Exhibit 42 Global Stationary Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 43 Global Stationary Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 44 Incremental Growth by Geography 2021 & 2027
Exhibit 45 Incremental Growth by Type 2021 & 2027
Exhibit 46 Global Medical Exoskeleton Market by Type
Exhibit 47 Global Medical Exoskeleton Market by Type: Incremental Growth
Exhibit 48 Global Medical Exoskeleton Market by Type: Absolute Growth
Exhibit 49 Global Rehabilitation Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 50 Global Rehabilitation Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 51 Incremental Growth by Geography 2021 & 2027
Exhibit 52 Global Augmentation Medical Exoskeleton Market: Incremental & Absolute Growth
Exhibit 53 Global Augmentation Medical Exoskeleton Market 2021–2027 ($ million)
Exhibit 54 Incremental Growth by Geography 2021 & 2027
Exhibit 55 Incremental Growth by Geography 2021 & 2027
Exhibit 56 Global Medical Exoskeleton Market by Geography
Exhibit 57 Global Medical Exoskeleton Market by Geography: Key Countries ($ million)
Exhibit 58 Global Medical Exoskeleton Market by Geography: Incremental Growth
Exhibit 59 Global Medical Exoskeleton Market by Geography: Absolute Growth
Exhibit 60 Medical Exoskeleton Market in North America: Key Countries
Exhibit 61 Global Medical Exoskeleton Market in North America: Incremental & Absolute Growth
Exhibit 62 Medical Exoskeleton Market in North America 2021–2027 ($ million)
Exhibit 63 Incremental Growth by Modality 2021 & 2027
Exhibit 64 Incremental Growth by Extremity 2021 & 2027
Exhibit 65 Incremental Growth by Mobility 2021 & 2027
Exhibit 66 Incremental Growth by Type 2021 & 2027
Exhibit 67 Incremental Growth in North America 2021 & 2027
Exhibit 68 Medical Exoskeleton Market in the US 2021–2027 ($ million)
Exhibit 69 Medical Exoskeleton Market in Canada 2021–2027 ($ million)
Exhibit 70 Medical Exoskeleton Market in Europe: Key Countries
Exhibit 71 Medical Exoskeleton Market in Europe: Incremental & Absolute Growth
Exhibit 72 Medical Exoskeleton Market in Europe 2021–2027 ($ million)
Exhibit 73 Incremental Growth by Modality 2021 & 2027
Exhibit 74 Incremental Growth by Extremity 2021 & 2027
Exhibit 75 Incremental Growth by Mobility 2021 & 2027
Exhibit 76 Incremental Growth by Type 2021 & 2027
Exhibit 77 Incremental Growth in Europe 2021 & 2027
Exhibit 78 Medical Exoskeleton Market in Germany 2021–2027 ($ million)
Exhibit 79 Medical Exoskeleton Market in the UK 2021–2027 ($ million)
Exhibit 80 Medical Exoskeleton Market in France 2021–2027 ($ million)
Exhibit 81 Medical Exoskeleton Market in Spain 2021–2027 ($ million)
Exhibit 82 Medical Exoskeleton Market in Italy 2021–2027 ($ million)
Exhibit 83 Medical Exoskeleton Market in APAC: Key Countries
Exhibit 84 Medical Exoskeleton Market in APAC: Incremental & Absolute Growth
Exhibit 85 Medical Exoskeleton Market in APAC 2021–2027 ($ million)
Exhibit 86 Incremental Growth by Modality 2021 & 2027
Exhibit 87 Incremental Growth by Extremity 2021 & 2027
Exhibit 88 Incremental Growth by Mobility 2021 & 2027
Exhibit 89 Incremental Growth by Type 2021 & 2027
Exhibit 90 Incremental Growth in APAC 2021 & 2027
Exhibit 91 Medical Exoskeleton Market in China 2021–2027 ($ million)
Exhibit 92 Medical Exoskeleton Market in Japan 2021–2027 ($ million)
Exhibit 93 Medical Exoskeleton Market in India 2021–2027 ($ million)
Exhibit 94 Medical Exoskeleton Market in Australia 2021–2027 ($ million)
Exhibit 95 Medical Exoskeleton Market in South Korea 2021–2027 ($ million)
Exhibit 96 Medical Exoskeleton Market in Latin America: Key Countries
Exhibit 97 Medical Exoskeleton Market in Latin America: Incremental & Absolute Growth
Exhibit 98 Medical Exoskeleton Market in Latin America 2021–2027 ($ million)
Exhibit 99 Incremental Growth by Modality 2021 & 2027
Exhibit 100 Incremental Growth by Extremity 2021 & 2027
Exhibit 101 Incremental Growth by Mobility 2021 & 2027
Exhibit 102 Incremental Growth by Type 2021 & 2027
Exhibit 103 Incremental Growth in Latin America 2021 & 2027
Exhibit 104 Medical Exoskeleton Market in Brazil 2021–2027 ($ million)
Exhibit 105 Medical Exoskeleton Market in Mexico 2021–2027 ($ million)
Exhibit 106 Medical Exoskeleton Market in Argentina 2021–2027 ($ million)
Exhibit 107 Medical Exoskeleton Market in the Middle East & Africa: Key Countries
Exhibit 108 Medical Exoskeleton Market in Latin America: Incremental & Absolute Growth
Exhibit 109 Medical Exoskeleton Market in the Middle East & Africa 2021–2027 ($ million)
Exhibit 110 Incremental Growth by Modality 2021 & 2027
Exhibit 111 Incremental Growth by Extremity 2021 & 2027
Exhibit 112 Incremental Growth by Mobility 2021 & 2027
Exhibit 113 Incremental Growth by Type 2021 & 2027
Exhibit 114 Incremental Growth in the Middle East & Africa 2021 & 2027
Exhibit 115 Medical Exoskeleton Market in Turkey 2021–2027 ($ million)
Exhibit 116 Medical Exoskeleton Market in Saudi Arabia 2021–2027 ($ million)
Exhibit 117 Medical Exoskeleton Market in South Africa 2021–2027 ($ million)
Exhibit 118 Ekso Bionics: Total Revenues 2018–2020 ($ million)
Exhibit 119 Ekso Bionics: R&D Expenditure 2018–2020 ($ million)
Exhibit 120 Ekso Bionics: Revenue by Region 2018–2020 ($ million)
Exhibit 121 Ekso Bionics: Revenue by Segment 2018–2020 ($ million)
Exhibit 122 ReWalk Robotics: Total Revenues 2018–2020 ($ million)
Exhibit 123 ReWalk Robotics: R&D Expenditure 2018–2020 ($ million)
Exhibit 124 ReWalk Robotics: Revenue by Geography 2018–2020 (%)
Exhibit 125 Parker Hannifin: Total Revenues 2018–2020 ($ million)
Exhibit 126 Parker Hannifin: Revenue by Geography 2019–2021 ($ million)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2015−2021
Table 3 Examples of Soft Actuator Medical Exoskeletons
Table 4 Examples of 3D-Printed Medical Exoskeletons
Table 5 EEG-based Control for Lower & Upper Limb Movements Exoskeletons
Table 6 Global Medical Exoskeleton Market by Geography
Table 7 Global Medical Exoskeleton Market by Modality
Table 8 Global Medical Exoskeleton Market by Extremity
Table 9 Global Medical Exoskeleton Market by Mobility
Table 10 Global Medical Exoskeleton Market by Type
Table 11 Some Commercial Powered Exoskeleton Products
Table 12 Overview of the Available Lower Extremity Medical Exoskeleton
Table 13 Stationary Medical Exoskeletons
Table 14 Major Medical Exoskeleton Startups in Europe
Table 15 Ekso Bionics: Major Product Offerings
Table 16 ReWalk Robotics: Major Product Offerings
Table 17 Parker Hannifin: Major Product Offerings
Table 18 Ottobock: Major Product Offerings
Table 19 Cyberdyne: Major Product Offerings
Table 20 Rex Bionics: Major Product Offerings
Table 21 DIH Medical: Major Product Offerings
Table 22 Wearable Robotics: Major Product Offerings
Table 23 Gogoa: Major Product Offerings
Table 24 ExoAtlet: Major Product Offerings
Table 25 Panasonic: Major Product Offerings
Table 26 Tyromotion: Major Product Offerings
Table 27 Honda: Major Product Offerings
Table 28 B-Temia: Major Product Offerings
Table 29 Bionic Power: Major Product Offerings
Table 30 Angel Robotics: Major Product Offerings
Table 31 Axosuits: Major Product Offerings
Table 32 BAMA Teknoloji: Major Product Offerings
Table 33 Biomotum: Major Product Offerings
Table 34 Bionic Yantra: Major Product Offerings
Table 35 Bioservo Technologies: Major Product Offerings
Table 36 Fourier Intelligence: Major Product Offerings
Table 37 FREE Bionics: Major Product Offerings
Table 38 Gloreha Idrogenet: Major Product Offerings
Table 39 Harmonic Bionics: Major Product Offerings
Table 40 HEXAR Humancare: Major Product Offerings
Table 41 Human in Motion Robotics: Major Product Offerings
Table 42 InteSpring: Major Product Offerings
Table 43 Marsi Bionics: Major Product Offerings
Table 44 Global Medical Exoskeleton Market by Modality 2021−2027 ($ million)
Table 45 Global Medical Exoskeleton Market by Modality 2021−2027 (%)
Table 46 North America Medical Exoskeleton Market by Modality 2021−2027 ($ million)
Table 47 North America Medical Exoskeleton Market by Modality 2021−2027 (%)
Table 48 Europe Medical Exoskeleton Market by Modality 2021−2027 ($ million)
Table 49 Europe Medical Exoskeleton Market by Modality 2021−2027 (%)
Table 50 APAC Medical Exoskeleton Market by Modality 2021−2027 ($ million)
Table 51 APAC Medical Exoskeleton Market by Modality 2021−2027 (%)
Table 52 Latin America Medical Exoskeleton Market by Modality 2021−2027 ($ million)
Table 53 Latin America Medical Exoskeleton Market by Modality 2021−2027 (%)
Table 54 Middle East & Africa Medical Exoskeleton Market by Modality 2021−2027 ($ million)
Table 55 Middle East & Africa Medical Exoskeleton Market by Modality 2021−2027 (%)
Table 56 Global Medical Exoskeleton Market by Extremity 2021−2027 ($ million)
Table 57 Global Medical Exoskeleton Market by Extremity 2021−2027 (%)
Table 58 North America Medical Exoskeleton Market by Extremity 2021−2027 ($ million)
Table 59 North America Medical Exoskeleton Market by Extremity 2021−2027 (%)
Table 60 Europe Medical Exoskeleton Market by Extremity 2021−2027 ($ million)
Table 61 Europe Medical Exoskeleton Market by Extremity 2021−2027 (%)
Table 62 APAC Medical Exoskeleton Market by Extremity 2021−2027 ($ million)
Table 63 APAC Medical Exoskeleton Market by Extremity 2021−2027 (%)
Table 64 Latin America Medical Exoskeleton Market by Extremity 2021−2027 ($ million)
Table 65 Latin America Medical Exoskeleton Market by Extremity 2021−2027 (%)
Table 66 Middle East & Africa Medical Exoskeleton Market by Extremity 2021−2027 ($ million)
Table 67 Middle East & Africa Medical Exoskeleton Market by Extremity 2021−2027 (%)
Table 68 Global Medical Exoskeleton Market by Mobility 2021−2027 ($ million)
Table 69 Global Medical Exoskeleton Market by Mobility 2021−2027 (%)
Table 70 North America Medical Exoskeleton Market by Mobility 2021−2027 ($ million)
Table 71 North America Medical Exoskeleton Market by Mobility 2021−2027 (%)
Table 72 Europe Medical Exoskeleton Market by Mobility 2021−2027 ($ million)
Table 73 Europe Medical Exoskeleton Market by Mobility 2021−2027 (%)
Table 74 APAC Medical Exoskeleton Market by Mobility 2021−2027 ($ million)
Table 75 APAC Medical Exoskeleton Market by Mobility 2021−2027 (%)
Table 76 Latin America Medical Exoskeleton Market by Mobility 2021−2027 ($ million)
Table 77 Latin America Medical Exoskeleton Market by Mobility 2021−2027 (%)
Table 78 Middle East & Africa Medical Exoskeleton Market by Mobility 2021−2027 ($ million)
Table 79 Middle East & Africa Medical Exoskeleton Market by Mobility 2021−2027 (%)
Table 80 Global Medical Exoskeleton Market by Type 2021−2027 ($ million)
Table 81 Global Medical Exoskeleton Market by Type 2021−2027 (%)
Table 82 North America Medical Exoskeleton Market by Type 2021−2027 ($ million)
Table 83 North America Medical Exoskeleton Market by Type 2021−2027 (%)
Table 84 Europe Medical Exoskeleton Market by Type 2021−2027 ($ million)
Table 85 Europe Medical Exoskeleton Market by Type 2021−2027 (%)
Table 86 APAC Medical Exoskeleton Market by Type 2021−2027 ($ million)
Table 87 APAC Medical Exoskeleton Market by Type 2021−2027 (%)
Table 88 Latin America Medical Exoskeleton Market by Type 2021−2027 ($ million)
Table 89 Latin America Medical Exoskeleton Market by Type 2021−2027 (%)
Table 90 Middle East & Africa Medical Exoskeleton Market by Type 2021−2027 ($ million)
Table 91 Middle East & Africa Medical Exoskeleton Market by Type 2021−2027 (%)
Table 92 Global Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 93 Global Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 94 Powered Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 95 Powered Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 96 Passive Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 97 Passive Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 98 Upper Extremity Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 99 Upper Extremity Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 100 Lower Extremity Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 101 Lower Extremity Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 102 Stationary Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 103 Stationary Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 104 Mobile Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 105 Mobile Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 106 Rehabilitation Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 107 Rehabilitation Medical Exoskeleton Market by Geography 2021−2027 (%)
Table 108 Augmentation Medical Exoskeleton Market by Geography 2021−2027 ($ million)
Table 109 Augmentation Medical Exoskeleton Market by Geography 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
